Danying Liao

1.4k total citations · 1 hit paper
20 papers, 885 citations indexed

About

Danying Liao is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Danying Liao has authored 20 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Danying Liao's work include CAR-T cell therapy research (9 papers), Cell Adhesion Molecules Research (3 papers) and Platelet Disorders and Treatments (2 papers). Danying Liao is often cited by papers focused on CAR-T cell therapy research (9 papers), Cell Adhesion Molecules Research (3 papers) and Platelet Disorders and Treatments (2 papers). Danying Liao collaborates with scholars based in China and United States. Danying Liao's co-authors include Heng Mei, Yu Hu, Peter J. Newman, Panida Lertkiatmongkol, Min Xu, Lili Luo, Jun Deng, Yadan Wang, Liqiong Cai and Zhihui Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Danying Liao

17 papers receiving 867 citations

Hit Papers

Endothelial functions of platelet/endothelial cell adhesi... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
    2016 410 citations Panida Lertkiatmongkol, Danying Liao et al. Current Opinion in Hematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danying Liao China 8 289 206 192 159 119 20 885
Junhua Zheng China 13 111 0.4× 252 1.2× 106 0.6× 67 0.4× 110 0.9× 37 734
Davide Raineri Italy 13 159 0.6× 372 1.8× 117 0.6× 89 0.6× 172 1.4× 26 821
Evi X. Stavrou United States 23 110 0.4× 222 1.1× 76 0.4× 48 0.3× 293 2.5× 44 1.4k
Manuela Baronio Italy 16 126 0.4× 356 1.7× 91 0.5× 81 0.5× 298 2.5× 45 985
Ming Jiang China 17 87 0.3× 239 1.2× 404 2.1× 80 0.5× 211 1.8× 68 1.1k
A Ríos United States 8 69 0.2× 170 0.8× 495 2.6× 59 0.4× 210 1.8× 14 1.2k
Victor Kokta Canada 20 111 0.4× 242 1.2× 440 2.3× 168 1.1× 137 1.2× 42 1.2k
Hye Lim Jung South Korea 19 45 0.2× 396 1.9× 184 1.0× 100 0.6× 112 0.9× 88 1.4k
Man Ki Chung South Korea 26 121 0.4× 263 1.3× 595 3.1× 96 0.6× 118 1.0× 96 2.1k
Jean‐Michel Boiron France 21 39 0.1× 255 1.2× 313 1.6× 130 0.8× 336 2.8× 60 1.7k

Countries citing papers authored by Danying Liao

Since Specialization
Citations

This map shows the geographic impact of Danying Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danying Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danying Liao more than expected).

Fields of papers citing papers by Danying Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danying Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danying Liao. The network helps show where Danying Liao may publish in the future.

Co-authorship network of co-authors of Danying Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Danying Liao. A scholar is included among the top collaborators of Danying Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danying Liao. Danying Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hu, Lijuan, Hui Yu, Heng Mei, et al.. (2024). Safety and efficacy of CD7-CAR-T cell in patients with relapsed/refractory T-lymphoblastic leukemia/lymphoma: Phase I dose-escalation/dose-expansion study.. Journal of Clinical Oncology. 42(16_suppl). 6515–6515. 2 indexed citations
4.
Luo, Wenjing, Yinqiang Zhang, Chenggong Li, et al.. (2024). BTK Inhibitor Synergizes with CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients with Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical Trial. Blood. 144(Supplement 1). 6546–6546. 1 indexed citations
5.
6.
Li, Chenggong, Jia Xu, Wenjing Luo, et al.. (2023). Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma. Leukemia. 38(1). 149–159. 45 indexed citations
7.
Zhang, Tong, Danying Liao, & Y. Hu. (2023). Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia. Translational Cancer Research. 12(5). 1175–1195. 7 indexed citations
8.
Luo, Wenjing, Chenggong Li, Yinqiang Zhang, et al.. (2023). P1393: BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH REFRACTORY OR RELAPSED B-CELL LYMPHOMA. HemaSphere. 7(S3). e4325339–e4325339. 1 indexed citations
9.
Zhang, Yinqiang, Mengyi Du, Danying Liao, et al.. (2023). Long-Term Follow-up of Humanized and Murine CD19 CAR-T Cell Therapy for B-Cell Malignancies. Blood. 142(Supplement 1). 3466–3466. 1 indexed citations
10.
Mei, Heng, Lu Tang, Huan Zhang, et al.. (2022). Autophagy Facilitates Cancer-Intrinsic Evasion of CAR T Cell-Mediated Cytotoxicity in B-Cell Malignancies. Blood. 140(Supplement 1). 634–635. 2 indexed citations
11.
Liao, Danying, Jesse A. Sundlov, Jieqing Zhu, et al.. (2021). Atomic Level Dissection of the Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) Homophilic Binding Interface: Implications for Endothelial Cell Barrier Function. Arteriosclerosis Thrombosis and Vascular Biology. 42(2). 193–204. 11 indexed citations
12.
Liao, Danying, Fen Zhou, Lili Luo, et al.. (2020). Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. The Lancet Haematology. 7(9). e671–e678. 328 indexed citations
13.
Liao, Danying & Huaibiao Li. (2020). Dissecting the Niche for Alveolar Type II Cells With Alveolar Organoids. Frontiers in Cell and Developmental Biology. 8. 419–419. 12 indexed citations
14.
15.
Luo, Lili, Min Xu, Mengyi Du, et al.. (2020). Early coagulation tests predict risk stratification and prognosis of COVID-19. Aging. 12(16). 15918–15937. 17 indexed citations
16.
Wu, Zhilin, Chen Chen, Jiajia Luo, et al.. (2020). EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2− shRNA to atherosclerotic macrophage in vitro. Scientific Reports. 10(1). 19636–19636. 14 indexed citations
17.
Wu, Zhilin, Chen Chen, Bo Zhang, et al.. (2019). <p>EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis</p>. International Journal of Nanomedicine. Volume 14. 2609–2618. 7 indexed citations
18.
Liao, Danying, Heng Mei, Yu Hu, Debra K. Newman, & Peter J. Newman. (2017). CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity. Life Sciences. 193. 186–193. 5 indexed citations
19.
Huang, Anliang, Danying Liao, Jinhu Ma, et al.. (2016). SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models. Oncology Reports. 36(6). 3283–3290. 7 indexed citations
20.
Lertkiatmongkol, Panida, Danying Liao, Heng Mei, Yu Hu, & Peter J. Newman. (2016). Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Current Opinion in Hematology. 23(3). 253–259. 410 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junhua Zheng Breakdown of academic impact, for papers by Davide Raineri Breakdown of academic impact, for papers by Evi X. Stavrou Breakdown of academic impact, for papers by Manuela Baronio Breakdown of academic impact, for papers by Ming Jiang Breakdown of academic impact, for papers by A Ríos Breakdown of academic impact, for papers by Victor Kokta Breakdown of academic impact, for papers by Hye Lim Jung Breakdown of academic impact, for papers by Man Ki Chung Breakdown of academic impact, for papers by Jean‐Michel Boiron
Rankless by CCL
2026